Archive for March 2019
Simon Walsh, MD
Simon Walsh is a Thoracic Radiologist and National Institute of Health Research Clinician Scientist working at the National Heart and Lung Institute, Imperial College, London. He is also a Machine Learning scientist. His research interests include diagnosis and outcome prediction in pulmonary fibrosis and the application of artificial intelligence to image analysis and computer vision.…
Read MoreMark Gelfand
Mr. Gelfand has more than 25 years of experience innovating medical devices in academic, startup and corporate environments. With Dr. Levin, he co-founded 10 venture-funded startups and served as the CTO to those ventures. Prior to becoming an entrepreneur, Mr. Gelfand worked at Nellcor Puritan Bennett, the world’s leading respiratory device company, where he was…
Read MoreJonathan Phillips
Dr. Jonathan Phillips joined Amgen in 2013 as a Principal Scientist and since March 2018 has served as the Global Discovery Research Lead for respiratory drug discovery where he is responsible for target identification and discovery strategies that ensure candidate molecules progress through early clinical development. Prior to joining Amgen, he worked in several respiratory…
Read MoreCayce Denton
Cayce Denton is a member of the healthcare investment team at Temasek, where she covers US therapeutics investing for both private and public companies. Private healthcare investments she has led at Temasek include Aerogen, Locana and Viela Bio. Previously, Cayce was in biotech venture capital at TPG Biotech, in operating roles at Genentech and Novartis,…
Read More